Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glass

Showing results (401-410 of 487) with videos related to

Pageof 49
Sort By:
Antiviral Therapy|April 9, 2008
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patientsTracy R Glass, Sabina De Geest, Bernard Hirschel, et al.
The Journal of Urology|December 23, 2000
Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group StudyM H Hussain, T R Glass, J Forman, et al.
AIDS (London, England)|September 28, 2016
Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concernLukas Muri, Anna Gamell, Alex J Ntamatungiro, et al.
HIV Medicine|June 22, 2022
Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in LesothoJennifer A Brown, Bienvenu L Nsakala, Kuena Mokhele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2020
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort StudyTracy R Glass, Huldrych F Günthard, Alexandra Calmy, et al.
Analytical Chemistry|October 3, 2014
Toward complete miniaturisation of flow injection analysis systems: microfluidic enhancement of chemiluminescent detectionAna M Gracioso Martins, Nick R Glass, Sally Harrison, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2021
Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based studyAndrea Kuemmerle, George Sikalengo, Fiona Vanobberghen, et al.
Plos One|October 8, 2015
Evaluation of Giant African Pouched Rats for Detection of Pulmonary Tuberculosis in Patients from a High-Endemic SettingKlaus Reither, Levan Jugheli, Tracy R Glass, et al.
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort StudyTracy R Glass, Manuel Battegay, Matthias Cavassini, et al.
Pageof 49

Showing results (401-410 of 487) with videos related to

Sort By:
Pageof 49
Antiviral Therapy|April 9, 2008
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patientsTracy R Glass, Sabina De Geest, Bernard Hirschel, et al.
The Journal of Urology|December 23, 2000
Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group StudyM H Hussain, T R Glass, J Forman, et al.
AIDS (London, England)|September 28, 2016
Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concernLukas Muri, Anna Gamell, Alex J Ntamatungiro, et al.
HIV Medicine|June 22, 2022
Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in LesothoJennifer A Brown, Bienvenu L Nsakala, Kuena Mokhele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2020
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort StudyTracy R Glass, Huldrych F Günthard, Alexandra Calmy, et al.
Analytical Chemistry|October 3, 2014
Toward complete miniaturisation of flow injection analysis systems: microfluidic enhancement of chemiluminescent detectionAna M Gracioso Martins, Nick R Glass, Sally Harrison, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2021
Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based studyAndrea Kuemmerle, George Sikalengo, Fiona Vanobberghen, et al.
Plos One|October 8, 2015
Evaluation of Giant African Pouched Rats for Detection of Pulmonary Tuberculosis in Patients from a High-Endemic SettingKlaus Reither, Levan Jugheli, Tracy R Glass, et al.
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort StudyTracy R Glass, Manuel Battegay, Matthias Cavassini, et al.
Pageof 49